Literature DB >> 18830254

MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients.

Ev Stralen, R J Leguit, H Begthel, L Michaux, A Buijs, H Lemmens, J M Scheiff, C Doyen, P Pierre, F Forget, H C Clevers, Bjeg Bast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18830254     DOI： 10.1038/leu.2008.284

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Risk of breast cancer in families with cleft lip and palate.

Authors:  Alexander Dietz; Dorthe Almind Pedersen; Rune Jacobsen; George L Wehby; Jeffrey C Murray; Kaare Christensen
Journal:  Ann Epidemiol       Date:  2011-10-28       Impact factor: 3.797

2.  Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms.

Authors:  Gary Lu; Ramya Muddasani; Robert Z Orlowski; Lynne V Abruzzo; Muzaffar H Qazilbash; M James You; Yaping Wang; Ming Zhao; Su Chen; Isabella Claudia Glitza; L Jeffrey Medeiros
Journal:  Arch Pathol Lab Med       Date:  2013-05       Impact factor: 5.534

3.  Both PAX4 and MAFA are expressed in a substantial proportion of normal human pancreatic alpha cells and deregulated in patients with type 2 diabetes.

Authors:  Rémy Bonnavion; Rami Jaafar; Julie Kerr-Conte; Fouzia Assade; Esther van Stralen; Emmanuelle Leteurtre; Célio Pouponnot; Sofia Gargani; François Pattou; Philippe Bertolino; Martine Cordier-Bussat; Jieli Lu; Chang Xian Zhang
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

4.  MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma.

Authors:  Ya-Wei Qiang; Shiqiao Ye; Yuhua Huang; Yu Chen; Frits Van Rhee; Joshua Epstein; Brian A Walker; Gareth J Morgan; Faith E Davies
Journal:  BMC Cancer       Date:  2018-07-06       Impact factor: 4.430

5.  MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.

Authors:  Wanyong Yang; Xi Lan; Dongmin Li; Tao Li; Shemin Lu
Journal:  BMC Cancer       Date:  2015-06-09       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.